Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Deloitte
US Department of Justice
Queensland Health
Healthtrust
Novartis
US Army
Cantor Fitzgerald
UBS
Colorcon

Generated: February 22, 2018

DrugPatentWatch Database Preview

EDECRIN Drug Profile

« Back to Dashboard

When do Edecrin patents expire, and when can generic versions of Edecrin launch?

Edecrin is a drug marketed by Aton and is included in two NDAs.

The generic ingredient in EDECRIN is ethacrynic acid. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Drug patent expirations by year for EDECRIN
Pharmacology for EDECRIN
Medical Subject Heading (MeSH) Categories for EDECRIN

US Patents and Regulatory Information for EDECRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton EDECRIN ethacrynate sodium INJECTABLE;INJECTION 016093-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aton EDECRIN ethacrynic acid TABLET;ORAL 016092-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Aton EDECRIN ethacrynic acid TABLET;ORAL 016092-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cerilliant
Merck
Boehringer Ingelheim
Accenture
Queensland Health
Citi
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot